This report analyzes the worldwide markets for Peptic Ulcers Testing in Millions of US$. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2015. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 29 companies including many key and ...
More »
Search ReportLinker
The Largest Collection of Market Research Reports
» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides
From +200,000 authoritative sources
This report analyzes the worldwide markets for Peptic Ulcers Testing in Millions of US$. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2015. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 29 companies including many key and niche players worldwide such as Beckman Coulter Inc., Kibion AB, Meretek Diagnostics Group of Otsuka America Pharmaceutical, Inc., Meridian Bioscience, Inc., Orion Diagnostica Oy, and Quidel Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Global Medical Equipment And Supply Industry
PEPTIC ULCER TESTING MCP-3417
A GLOBAL STRATEGIC BUSINESS REPORT
CONTENTS
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
CAGR Disparities Between Historic & Current Data I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Peptic Ulcer Tests I-4
II. EXECUTIVE SUMMARY
1. Industry Highlights II-1
2. Peptic Ulcers - A Prelude II-2
3. Classification of Peptic Ulcers II-3
Gastric Ulcers II-3
Duodenal Ulcers II-3
Bleeding Peptic Ulcers II-3
4. Conditions or Causes of Peptic Ulcers II-5
H. Pylori: The Major Cause of Peptic Ulcers II-5
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) II-5
Excess Acid Production in the Stomach II-6
5. Discovery of H. Pylori - Paradigm Change in Ulcer Treatment II-7
H. Pylori - Most Harmful Class I Carcinogen II-7
Diseases Caused by H. Pylori Infection II-7
Transmission of H. Pylori II-8
Eradication of H. Pylori II-8
6. Peptic Ulcer Tests II-9
Testing for the Presence of H. Pylori II-9
Diagnostic Assays for Detection of H. Pylori II-9
Invasive Tests II-10
Non-Invasive Tests II-10
Tissue Tests: Endoscopy of the Stomach II-10
Gastrointestinal Endoscopy: Gold Standard in Diagnoses of
Upper GI Diseases II-10
The Endoscopic Procedure II-10
Blood Test or Serological Test II-11
Types of Blood Tests II-11
Urea Breath Test (UBT) - The Most Effective Diagnoses for
Detection of H. Pylori II-11
Urea Breath Test: A Convenient and Affordable Method for
Detection & Treatment of Peptic Ulcer II-12
Types of Urea Breath Tests II-12
Carbon-14-Urea Breath Test II-12
Precautionary Measures to be taken Prior to Performance of
UBT II-12
Federal Legislation Governing the 14C UBT II-13
Carbon-13-Urea Breath Test II-13
Breath Tests Vs Other Diagnostic Assays II-13
Barium X-rays II-13
Noster System AB’s BreathCard™ and Heliprobe™ Systems II-14
Other Diagnostic Devices and Tests II-14
FlexSure. HP II-14
QuickView II-15
CLOtest II-15
CLOser II-15
Automated Breath 13C Analyzer (ABCA) II-15
Helicobacter Pylori Detection Via 13C-UBT II-16
Pytest II-16
MicroCOUNT II-16
EZ-H.P. - The 10 Minute Ulcer Screening Test II-16
The Single-Step H. Pylori Test II-16
Helisal ™ Rapid Blood Test II-17
7. Treatment of Peptic Ulcers II-18
Perplexity of Ulcers II-18
A New Page Opens in the Treatment of Ulcers II-18
Factors Affecting Peptic Ulcer Conditions II-18
Ulcer Therapies for Preventing PUD Recurrence: A Review II-18
Advanced-Generation Macrolide Antibiotic Biaxin Therapy II-19
The Two-Week Double and Triple Therapies II-19
Medication II-19
H2-blockers II-19
Acid Pump Inhibitors II-20
Mucosal Protective Medications II-20
8. Drugs Used to Cure Non-Steroidal Anti- Inflammatory Drug
(NSAID) Induced Ulcers II-21
Handling NSAID-Induced Ulcers II-21
Antacids II-21
Antibiotics II-21
Side Effects Associated with Antibiotics II-21
Misoprostol II-21
Cimetidine II-21
Mucosta II-21
Sucralfate (Carafate) II-21
9. The Need for Surgery II-22
10. Research & Development II-23
Probiotics’ Effectiveness in Peptic Ulcer Treatment II-23
Peptic Ulcer - Relation with Oral Hygiene II-23
PPIs Relegate Peptic Ulcer Bleeding II-23
11. Product Innovations/Introductions II-24
Sanko Junyaku to Introduce Diagnostic Kit for H. pylori Infection II-24
Torrent Pharmaceuticals Releases Nexpro Fast II-24
Wyeth Laboratories Launches HeliMet Triple Pack II-24
AstraZeneca Introduces Nexium II-24
Biomerica Launches Pepgen Test II-24
Norton Healthcare Introduces Famotidine Tablets II-25
12. Recent Industry Activity II-26
Meretek Strikes Deal with PAML II-26
Meretek Diagnostics and OAPI Announce Merger II-26
Meridian’s Partnership with Merck KGaA II-26
Meridian Bags FDA Clearance for Stomach Ulcer Test II-26
Kibion AB Acquires Noster System II-26
Takeda Pharmaceutical Bags Additional Approval for Takepron II-27
UCB’s Licensing Agreement with Boryung II-27
Eisai and GlaxoSmithKline Sign Co-marketing Agreement II-27
Yuhan Gains KFDA Approval for Duodenal Ulcers’ Drug II-27
Yamanouchi Signs Agreement with Aventis Pharma II-27
Oridion Bags FDA Clearance for BreathID® H. Pylori Breath Test II-27
Quidel Corporation Unveils Latest Version of H. Pylori Test II-28
Teikoku Chemical Licenses Technology to Eisai II-28
Trinity Biotech Bags FDA Clearance for Uni-Gold™ Test II-28
EPI Bags FDA Clearance for PP-CAP® IgA EIA II-28
13. Focus on Select Global Players II-29
Beckman Coulter, Inc. (USA) II-29
Kibion AB (Sweden) II-29
Meretek Diagnostics Group of Otsuka America Pharmaceutical,
Inc. (USA) II-29
Meridian Bioscience, Inc. (USA) II-29
Orion Diagnostica Oy (Finland) II-30
Quidel Corporation (USA) II-30
14. Global Market Perspective II-31
Table 1: World Recent Past, Current & Future Analysis for
Peptic Ulcer Testing by Geographic Region - USA, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and
Rest of World Markets Independently Analyzed with Annual
Revenue Figures in US$ Million for Years 2001 through 2010
(includes corresponding Graph/Chart) II-31
Table 2: World Long Term Projections for Peptic Ulcer Testing
by Geographic Region - USA, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-32
Table 3: World Historic Review for Peptic Ulcer Testing by
Geographic Region - USA, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 1991 through 2000 (includes corresponding
Graph/Chart) II-33
Table 4: World 15-Year Perspective for Peptic Ulcer Testing
by Geographic Region - Percentage Breakdown of Dollar Sales
for USA, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America and Rest of World Markets for Years 1998, 2008, &
2012 (includes corresponding Graph/Chart) II-34
III. MARKET
1. The United States III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Product Launches/Developments III-1
Strategic Corporate Developments III-2
Key Players III-3
B.Market Analytics III-5
Table 5: US Recent Past, Current & Future Analysis for
Peptic Ulcer Testing with Annual Revenue Figures in US$
Million for Years 2001 through 2010 (includes corresponding
Graph/Chart) III-5
Table 6: US Long Term Projections for Peptic Ulcer Testing
with Annual Revenue Figures in US$ Million for Years 2011
through 2015 (includes corresponding Graph/Chart) III-5
Table 7: US Historic Review for Peptic Ulcer Testing with
Annual Revenue Figures in US$ Million for Years 1991
through 2000 (includes corresponding Graph/Chart) III-6
2. Japan III-7
A.Market Analysis III-7
Current and Future Analysis III-7
Strategic Corporate Developments III-7
Product Launch III-7
B.Market Analytics III-8
Table 8: Japanese Recent Past, Current & Future Analysis for
Peptic Ulcer Testing with Annual Revenue Figures in US$
Million for Years 2001 through 2010 (includes corresponding
Graph/Chart) III-8
Table 9: Japanese Long Term Projections for Peptic Ulcer
Testing with Annual Revenue Figures in US$ Million for
Years 2011 through 2015 (includes corresponding Graph/Chart) III-8
Table 10: Japanese Historic Review for Peptic Ulcer Testing
with Annual Revenue Figures in US$ Million for Years 1991
through 2000 (includes corresponding Graph/Chart) III-9
3. Europe III-10
A.Market Analysis III-10
Current and Future Analysis III-10
Product Launch III-10
Strategic Corporate Development III-10
Key Players III-11
B.Market Analytics III-12
Table 11: European Recent Past, Current & Future Analysis
for Peptic Ulcer Testing Annual Revenue Figures in US$
Million for Years 2001 through 2010 (includes corresponding
Graph/Chart) III-12
Table 12: European Long Term Projections for Peptic Ulcer
Testing with Annual Revenue Figures in US$ Million for
Years 2011 through 2015 (includes corresponding
Graph/Chart) III-12
Table 13: European Historic Review for Peptic Ulcer Testing
with Annual Revenue Figures in US$ Million for Years 1991
through 2000 (includes corresponding Graph/Chart) III-13
4. Asia-Pacific III-14
A.Market Analysis III-14
Current and Future Analysis III-14
Product Launch III-14
Strategic Corporate Developments III-14
B.Market Analytics III-15
Table 14: Asia-Pacific Recent Past, Current & Future
Analysis for Peptic Ulcer Testing with Annual Revenue
Figures in US$ Million for Years 2001 through 2010 (includes
corresponding Graph/Chart) III-15
Table 15: Asia Pacific Long Term Projections for Peptic
Ulcer Testing with Annual Revenue Figures in US$ Million
for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-15
Table 16: Asia-Pacific Historic Review for Peptic Ulcer
Testing with Annual Revenue Figures in US$ Million for Years
1991 through 2000 (includes corresponding Graph/Chart) III-16
5. Latin America III-17
Market Analysis III-17
Current and Future Analysis III-17
Table 17: Latin America Recent Past, Current & Future
Analysis for Peptic Ulcer Testing with Annual Revenue
Figures in US$ Million for Years 2001 through 2010 (includes
corresponding Graph/Chart) III-17
Table 18: Latin America Long Term Projections for Peptic
Ulcer Testing with Annual Revenue Figures in US$ Million
for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-18
Table 19: Latin America Historic Review for Peptic Ulcer
Testing with Annual Revenue Figures in US$ Million for
Years 1991 through 2000 (includes corresponding
Graph/Chart) III-18
6. Rest of World III-19
A.Market Analysis III-19
Current and Future Analysis III-19
Strategic Corporate Development III-19
B.Market Analytics III-19
Table 20: Rest of World Recent Past, Current & Future
Analysis for Peptic Ulcer Testing with Annual Revenue
Figures in US$ Million for Years 2001 through 2010
(includes corresponding Graph/Chart) III-19
Table 21: Rest of World Long Term Projections for Peptic
Ulcer Testing with Annual Revenue Figures in US$ Million
for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-20
Table 22: Rest of World Historic Review for Peptic Ulcer
Testing with Annual Revenue Figures in US$ Million for
Years 1991 through 2000 (includes corresponding
Graph/Chart) III-20
IV. COMPETITIVE LANDSCAPE
